Loading...
Concordance of Programmed Death-Ligand 1 Expression between SP142 and 22C3/SP263 Assays in Triple-Negative Breast Cancer
PURPOSE: Triple-negative breast cancer (TNBC) represents a major clinical challenge due to its aggressive and metastatic behavior and the lack of available targeted therapies. Therefore, therapeutic strategies are needed to improve TNBC patient management. Recently, atezolizumab and nab-paclitaxel c...
Na minha lista:
| Udgivet i: | J Breast Cancer |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Breast Cancer Society
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7311361/ https://ncbi.nlm.nih.gov/pubmed/32595992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2020.23.e37 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|